Literature DB >> 36113371

Castleman disease of the parapharyngeal space: Diagnosis and management.

S Jbali1, S Zarraa2, A Hadhri2, G E F Noubbigh3, S Yahyaoui2, C Nasr2.   

Abstract

INTRODUCTION: Castleman's disease (CD) is a rare and benign disease often identified in the mediastinum with few cases in the head and neck area. Parapharyngeal Castleman's disease was rarely reported in the literature. The aim of our work was to discuss the management of this particular location of CD. It was about a case report that has been reported in line with the SCARE 2020 criteria (Agha et al., 2020 [1]). CASE
PRESENTATION: We report the case of a 53-year-old female patient who presented a left parotid tumefaction. Radiological investigations showed a parapharyngeal mass that was surgically removed. Definitive pathologic report concluded to Castleman's disease. She presented, one year later, a retropharyngeal recurrence, which was treated by radiotherapy with good response. CLINICAL DISCUSSION AND
CONCLUSION: Castleman's disease located in parapharyngeal spaces is an entity that was rarely reported in the literature. Surgical excision is the golden standard treatment. Radiotherapy is also an effective treatment that can be offered for unresectable cases or recurrences of Castleman's disease.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Case report; Castleman's disease; Parapharyngeal; Radiation therapy; Surgery

Year:  2022        PMID: 36113371      PMCID: PMC9568718          DOI: 10.1016/j.ijscr.2022.107599

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  24 in total

1.  Castleman's disease restricted to the parapharyngeal space.

Authors:  F Ottaviani; J Galli; S Di Girolamo; G Almadori
Journal:  J Otolaryngol       Date:  1999-04

2.  Castleman's disease in the head and neck region: Meta-analysis of reported cases in Taiwan and literature review.

Authors:  Chien-Yu Lin; Yen-Liang Chang
Journal:  J Formos Med Assoc       Date:  2010-12       Impact factor: 3.282

3.  Castleman disease in the parapharyngeal space: unusual presentation and differential diagnostic imaging features of the disease.

Authors:  Ozan Bagis Ozgursoy; Mahmut Demirtas; Isinsu Kuzu; Tevfik Akturk
Journal:  J Otolaryngol Head Neck Surg       Date:  2009-10

4.  Surgical management of primary parapharyngeal space tumors: a 10-year review.

Authors:  Xiaoling Shi; Lei Tao; Xiaoming Li; Haitao Wu; Weiting Huang; Xiaoling Chen; Cai Li; Yan Shen; Qi Chen; Di Tang; Chunsheng Wei; Dehui Wang; Liang Zhou
Journal:  Acta Otolaryngol       Date:  2016-12-06       Impact factor: 1.494

5.  Castleman disease of the neck: CT and MR imaging findings.

Authors:  Xin-Hua Jiang; Hao-Ming Song; Qing-Yu Liu; Yun Cao; Guo-Hong Li; Wei-Dong Zhang
Journal:  Eur J Radiol       Date:  2014-09-02       Impact factor: 3.528

6.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

Review 7.  The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.

Authors:  W B Bowne; J J Lewis; D A Filippa; R Niesvizky; A D Brooks; M E Burt; M F Brennan
Journal:  Cancer       Date:  1999-02-01       Impact factor: 6.860

Review 8.  Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature.

Authors:  Iris A C de Vries; Marjolein M S van Acht; Thomas B J Demeyere; Marnix L M Lybeert; Jean-Paul de Zoete; Grard A P Nieuwenhuijzen
Journal:  Radiat Oncol       Date:  2010-02-02       Impact factor: 3.481

9.  [Primary tumours of the parapharyngeal space. Our experience in 51 patients].

Authors:  Vanessa Suárez-Fente; José Luis Llorente-Pendás; Justo Gómez-Martínez; Luis Amando García-González; Fernando López-Alvarez; Carlos Suárez-Nieto
Journal:  Acta Otorrinolaringol Esp       Date:  2009 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.